klh-2109
Small moleculeexperimental
Clinical trial activity
7 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
7
Phase 3
3
Phase 4
0
Earliest trial started Jul 14, 2011 (NCT01395940)
Timeline
Indications
Mechanism of action
- Gonadotropin-releasing hormone receptorANTAGONIST
GNRHR antagonist
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL3544948 ↗
Also known as
- klh-2109
- klh-2109
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07015268 | Phase 3 | Jun 30, 2025 | Kissei Pharmaceuticals |
| NCT05440383 | Phase 3 | Oct 11, 2022 | Kissei Pharmaceuticals |
| NCT05445167 | Phase 3 | Oct 11, 2022 | Kissei Pharmaceuticals |
| NCT02778919 | Phase 2 | May 18, 2016 | Kissei Pharmaceuticals |
| NCT01629420 | Phase 2 | Jun 25, 2012 | Kissei Pharmaceuticals |
| NCT01533532 | Phase 2 | Feb 12, 2012 | Kissei Pharmaceuticals, Kwame Nkrumah University of Science and Technology |
| NCT01395940 | Phase 2 | Jul 14, 2011 | Kissei Pharmaceuticals |
Showing 7 of 7 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Kissei Pharmaceuticals | For profit | 7 | 7 | 2 | 2011 |
| Kwame Nkrumah University of Science and Technology | Academic/Hospital | 1 | 0 | 1 | 2012 |
2 organizations
Page 1 / 1